课题基金 / 基金详情

How can guidelines be optimised to help achieve the rational use of antibiotics after the Covid-19 pandemic?

How can guidelines be optimised to help achieve the rational use of antibiotics after the Covid-19 pandemic?
如何优化指南以帮助实现 Covid-19 大流行后合理使用抗生素?
批准号:
2587230
负责人:
金额:
$0.0万
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
这个博士项目旨在使用混合方法来了解指南如何在新冠肺炎之后优化以提高抗生素的使用,为指南的制定者和执行者提供新的见解。全球抗菌素耐药性一直在增加,部分原因是医疗保健环境中抗生素的高使用率。指南在影响抗生素使用方面发挥着关键作用,特别是在初级保健环境中,处方是基于临床判断而不是精确的诊断测试。有可能影响抗生素使用的一个指南是Aware指数。Aware由世界卫生组织(WHO)于2017年创建,用于将基本药物清单中的抗生素分类为三组:Access(治疗最常见感染的第一和第二选择抗生素)、Watch(具有较高耐药性潜力的抗生素)和Reserve(最后治疗)。这些类别旨在通过作为系统、设施和处方人员的措施和目标的基础来指导管理方案。在英国,AWARE是2019-2024年AMR国家行动计划(NAP)的一部分,由英国公共卫生署(PHE)用于监测以及在初级和二级保健环境中进行研究。然而,目前尚不清楚Aware是否或如何转化为初级保健临床实践。该研究项目将利用流行病学和人类学方法的互补优势,了解指南如何在英国新冠肺炎事件后为改善抗生素使用而优化,为指南制定者和执行者提供新的见解。该项目的流行病学(定量)方面将使用电子健康记录中的抗生素处方数据。我将比较英格兰和爱尔兰的处方模式,以量化Aware指数的影响。Aware已在英国的2019-2024年AMR国家行动计划中实施,但尚未列入爱尔兰的国家行动计划,因此我将能够通过评估一段时间(在英格兰实施之前和之后)抗生素使用的变化,并与对照国家(爱尔兰)进行比较,来确定Aware是否对英格兰的处方产生了影响。该项目的人类学(定性)方面将涉及关键的线人访谈和人种学田野调查。将与参与国家抗生素使用政策设置的3名个人进行关键信息提供人的访谈,并将在整个项目中重复进行,以使这项研究能够共同完成。人种学田野工作将在英国的2个一般实践中进行,在那里我将观察药物管理团队(他们一直是英国AMR管理干预的焦点)、临床工作人员和药剂师之间的会议。定性和定量的结果将合并到一个最终解释中,在那里我将确定这项研究不同元素之间的一致和不同之处。
英文摘要
This PhD project aims to use a mixed-methods approach to understand how guidelines can be optimised for improving antibiotic use after Covid-19, providing new insights to be used by guideline setters and implementers.Antimicrobial resistance (AMR) has been increasing globally, in part due to high rates on antibiotic use in healthcare settings. Guidelines play a pivotal role in influencing antibiotic use, particularly in primary care settings where prescribing is based on clinical judgement rather than a precise diagnostic test. One guideline that has potential to influence antibiotic use is the AWaRe Index. AWaRe was created by the World Health Organization (WHO) in 2017 as a way of categorising antibiotics in the Essential Medicines List into three groups: Access (first- and second-choice antibiotics for treating most common infections), Watch (antibiotics with a higher potential for developing resistance) and Reserve (last resort treatments). These categories are intended to guide stewardship programmes by being the basis of measures and targets for systems, facilities and prescribers. In the UK, AWaRe is part of the 2019-2024 AMR National Action Plan (NAP), is used for monitoring by Public Health England (PHE) and in research in both primary and secondary care settings. However, it is not yet clear if or how AWaRe is translated into primary care clinical practice.This research project will draw on the complementary strengths of epidemiological and anthropological methods to understand how guidelines can be optimised for improving antibiotic use after Covid-19 in the UK, providing new insights to be used by guideline setters and implementers.The epidemiological (quantitative) aspect of this project will use antibiotic prescribing data from electronic health records. I will compare patterns in prescribing between England and Ireland in order to quantify the effects of the AWaRe Index. AWaRe was implemented in the UK's 2019-2024 AMR National Action Plan, but is not yet in Ireland's National Action Plan, so I will be able to determine if AWaRe has had an impact on prescribing in England by assessing changes in antibiotic use over time (before and after it was implemented in England), and compared to a control country (Ireland). The anthropological (qualitative) aspects of this project will involve key informant interviews and ethnographic fieldwork. Key informant interviews will be conducted with 3 individuals who are involved in national antibiotic use policy settings and will be repeated throughout the project to enable the co-production of this research. The ethnographic fieldwork will be conducted at 2 general practices in the UK and where I will observe meetings between Medicine Management Teams (who have been the focal points for UK AMR stewardship interventions), clinical staff and pharmacists.The qualitative and quantitative findings will be merged into one final interpretation, where I will identify areas of agreement and disagreement between the different elements of this research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金